NumFin

Accelerate Diagnostics, Inc.

Sümbol: AXDX

NASDAQ

0.9248

USD

Turuhind täna

  • -0.2405

    P/E suhe

  • 0.0056

    PEG suhe

  • 20.04M

    MRK Cap

  • 0.00%

    DIV tootlus

Accelerate Diagnostics, Inc. (AXDX) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Accelerate Diagnostics, Inc. (AXDX) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 3.308 M, mis on 1.343 % gowth. Kogu perioodi keskmine brutokasum on 1.461 M, mis on 1.435 %. Keskmine brutokasumi suhtarv on 0.707 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.014 %, mis on võrdne -1.097 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Accelerate Diagnostics, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.518. Käibevara valdkonnas on AXDX aruandlusvaluutas 24.466. Märkimisväärne osa neist varadest, täpsemalt 13.219, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust -0.710%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 0, kui neid on, aruandlusvaluutas. See näitab erinevust 0.000% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 36.102 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.494%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud -19.888 aruandlusvaluutas. Selle aspekti aastane muutus on -0.107%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 2.622, varude hind on 3.31 ja firmaväärtus 0, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 0. Kontovõlad ja lühiajalised võlad on vastavalt 4.8 ja 2.29. Koguvõlg on 39.22, netovõlg on 27.08. Muud lühiajalised kohustused moodustavad 3.41, mis lisandub kohustuste kogusummale 51.25. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996

balance-sheet.row.cash-and-short-term-investments

96.9413.245.663.6
68.3
108.5
166.5
109.2
77.8
132.4
66.7
42
14.3
0.8
0.3
0.9
1.2
1.4
3
5.6
7.2
8.7
8.6
9.5
10.4
10.3
10.4
7.9
1.4

balance-sheet.row.short-term-investments

5.951.110.723.7
32.5
47.4
100.2
80.6
58.5
11.8
13.1
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

10.062.62.42.3
1.6
3.2
1.9
1.9
0
0.1
0.1
0
0.8
0.6
0.4
0
0
0
0
0.3
0.2
0
1.2
0.1
0.3
1.1
1.4
0.9
0.4

balance-sheet.row.inventory

17.243.35.25.1
9.2
8.1
7.7
8.1
0.5
1.6
0
0
0
0
0
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

13.345.321.6
1.8
1.2
0.6
0.5
0.2
0
0.3
0.1
0
0
0
0
0
0
0
0.2
0
0
0
0
0
0
0
0.2
0.2

balance-sheet.row.total-current-assets

141.9824.55673.3
82
121.9
177.6
120.5
78.4
134.2
67.1
42.1
15
1.4
0.8
0.9
1.4
1.5
3.1
6.1
7.5
8.8
9.9
9.7
11.1
11.7
12
9
2

balance-sheet.row.property-plant-equipment-net

24.445.17.87.9
9.3
11.8
7.3
4.9
4.3
5
2.5
1
0
0
0
0
0
0.1
0.2
0.2
0.2
0.1
0.1
0.1
0.2
0.3
0.3
0.2
0.1

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0000
0
0
0.1
0.1
0.1
0.2
0.2
0.2
0.7
0
0
0
3.3
3.5
3.7
3.9
4.1
4.3
4.6
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0000
0
0
0.1
0.1
0.1
0.2
0.2
0.2
0.7
2.8
3
3.2
3.3
3.5
3.7
3.9
4.1
4.3
4.6
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
0
0
0
0
1.5
1.3
1.2
1.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
8
0
0
0
0
0
0
0
0.5
0
1.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

5.151.81.21.8
-5.9
0.8
0.2
1.2
0
0
0
0
0
0.7
0
0
1.1
1
0.9
0.8
0.9
0.6
0.4
1
1.8
2.2
1.7
0.6
0.2

balance-sheet.row.total-non-current-assets

29.596.999.7
11.4
12.6
7.6
6.2
4.4
5.2
2.7
1.3
2.2
4.8
5.5
4.3
4.5
4.6
4.8
4.9
5.2
5
5.1
1.1
2
2.4
1.9
0.8
0.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

171.5731.46583
93.4
134.4
185.3
126.7
82.9
139.3
69.8
43.4
17.2
6.3
6.3
5.2
5.8
6.1
7.8
11
12.7
13.7
15
10.7
13.1
14.1
14
9.8
2.3

balance-sheet.row.account-payables

17.164.84.52
1.3
2.4
1.3
2.1
1
2.6
2.1
0.5
0.1
0
0
0
0.1
0.1
0.1
0.2
0.1
0.2
0.1
0.2
0.2
0.2
0.4
0.1
0.1

balance-sheet.row.short-term-debt

65.882.358.40.7
1.1
0.5
0
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

123.6936.119.2110.4
148.9
133.6
120.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

2.211.100
-8
0
0
0
1
1
1
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0.83---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

85.533.43.23.8
4.3
5.1
6.2
3.6
3
2.5
0.5
0.5
1.2
0
0
0
0
0
0
0.3
0
0
0.5
0.2
0.1
0.1
0.4
0.3
0.2

balance-sheet.row.total-non-current-liabilities

132.2239.220.7111.2
149.3
133.6
120.1
0
1
1
1
0.8
1
1.4
1.3
1.2
1.1
1.1
0.9
0.8
0.7
0.6
0.5
0.6
1.2
1.1
0.8
0.2
0.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

10.910.84.33
3.6
4
0
0
0
0
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

303.8851.387.3118.1
156.2
141.8
127.9
6.8
5
6.3
3.8
1.9
2.4
1.4
1.4
1.3
1.4
1.3
1.1
1.3
1
1
1.3
1.1
1.8
1.8
1.6
0.6
0.4

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0.1400.10.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
23
0
0
0
0
0
0
12.9
12.9
12.5
12.3
8.2
8.3
8.4
8.5
0
0

balance-sheet.row.retained-earnings

-2598.76-668.9-607.2-570.7
-493
-414.7
-330.3
-240.8
-177.3
-110.9
-65.4
-34.5
-15.8
-10.5
-10.1
-10.8
-10
-8.4
-6.4
-3.4
-1.3
-0.4
1
1.4
2.9
3.8
3.8
0.9
-0.1

balance-sheet.row.accumulated-other-comprehensive-income-loss

-2.26-0.6-0.4-0.1
0.1
-0.1
-0.1
0.1
-0.2
0
0
0
0
0
0
0
-0.3
-0.3
-0.3
0
0
0.4
0.4
0
0
0
-0.3
0
0

balance-sheet.row.other-total-stockholders-equity

2468.57649.6585.3535.6
430
407.3
387.8
360.6
255.3
243.9
131.4
75.9
7.7
15.3
15
14.6
14.7
13.5
13.4
0.2
0.2
0.3
0.1
0
0
0
0.3
8.3
2

balance-sheet.row.total-stockholders-equity

-132.31-19.9-22.3-35.1
-62.8
-7.4
57.4
119.9
77.8
133
66
41.5
14.8
4.8
4.9
3.9
4.4
4.9
6.7
9.7
11.7
12.7
13.7
9.6
11.3
12.2
12.4
9.2
1.9

balance-sheet.row.total-liabilities-and-stockholders-equity

171.5731.46583
93.4
134.4
185.3
126.7
82.9
139.3
69.8
43.4
17.2
6.3
6.3
5.2
5.8
6.1
7.8
11
12.7
13.7
15
10.7
13.1
14.1
14
9.8
2.3

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

-132.31-19.9-22.3-35.1
-62.8
-7.4
57.4
119.9
77.8
133
66
41.5
14.8
4.8
4.9
3.9
4.4
4.9
6.7
9.7
11.7
12.7
13.7
9.6
11.3
12.2
12.4
9.2
1.9

balance-sheet.row.total-liabilities-and-total-equity

171.57---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

5.951.110.723.7
32.5
47.4
100.2
80.6
58.5
11.8
13.1
12
1.5
1.3
1.2
1.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

190.3939.277.5111.1
150
134.1
120.1
0
0
0
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

99.427.142.671.2
114.2
73.1
53.8
-28.5
-19.2
-120.6
-53.4
-30
-14.3
-0.8
-0.3
-0.9
-1.2
-1.4
-3
-5.6
-7.2
-8.7
-8.6
-9.5
-10.4
-10.3
-10.4
-7.9
-1.4

Rahavoogude aruanne

Accelerate Diagnostics, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.163 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 4, mis tähistab -85.567 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 0.29 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli 8660000.000. See on -0.303 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 3.25, 0, -10, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte 0 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -0.98, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996

cash-flows.row.net-income

-54.87-61.6-62.5-77.7
-78.2
-84.3
-88.3
-64
-66.4
-45.5
-30.9
-15.3
-5.3
-0.4
0.6
-0.7
-1.7
-1.9
-3
-2.1
-1.7
-1.4
-0.4
-1.5
-0.9
0.1
2.9
1
1.1

cash-flows.row.depreciation-and-amortization

3.253.332.5
3
2.6
2.6
2.2
2.4
1.8
0.9
0.4
0.2
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.6
0.9
0.7
0.3
0.2
0.1

cash-flows.row.deferred-income-tax

0-1.20-5.6
0.5
0.4
0.1
0
0
0
0
-3.8
0
0.4
0
0
0
0
0
0
0
0
0
0
-0.4
0
0.4
0.1
-0.1

cash-flows.row.stock-based-compensation

5.395.410.622
16.5
12.6
14.7
13.9
8.8
8.4
9.6
3.8
0.8
0.1
0
0
0
0
0
0
0
0
0
0
0
0
-0.1
0
0

cash-flows.row.change-in-working-capital

4.934.92.3-0.1
-3.3
-6.1
-3.5
-8.4
1.4
0
1.4
1.3
1.5
0.5
-1.7
0
0.2
0.1
0
0.2
0.1
0.6
-0.6
-0.1
1.1
0.4
0
-0.3
-0.1

cash-flows.row.account-receivables

-0.23-0.2-0.1-0.8
1.6
-1.4
0.1
-1.9
0
0
-0.1
0.7
0.6
0.4
-1.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0.450.4-0.2-0.4
-1.4
-3.7
-4.5
-7.8
2.7
-0.4
-0.1
-0.5
0
0
0
0
0
-0.1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0.290.32.90.3
-1
1
-0.7
1.1
-1.2
0.3
1.3
0.2
0
2.8
0
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

4.424.4-0.30.8
-2.6
-2.1
1.6
0.2
-0.1
0.1
0.2
0.8
0.9
-2.7
0
0
0.1
0.2
0
0.2
0.1
0
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

1.19.1-2.111.5
11.2
10
6.8
0.6
0.4
0.2
0.3
3.9
2
-0.4
0
0.2
0.3
0
0.1
0
0.1
0.6
0.1
0.9
-0.3
-0.1
0.1
-0.1
0.1

cash-flows.row.net-cash-provided-by-operating-activities

-40.2000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-1.03-1-0.6-0.6
-1.4
-0.3
-1
-3
-2.4
-3.7
-1.9
-1.2
-0.1
-0.1
0
-0.1
-0.1
0
-0.1
-0.1
-0.1
-0.1
0
-0.1
0
0
-0.2
-0.1
0

cash-flows.row.acquisitions-net

000.60.6
1.4
0.3
1
-8.6
-7.3
1.1
1.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

00-27.5-30.1
-46.9
-50.2
-120.6
-82.3
-74.1
-12.4
-7.7
-12
-0.1
-0.1
-0.1
0
0
0
0
-0.1
0
-0.1
-0.1
-0.1
0
-0.1
-0.1
0
0

cash-flows.row.sales-maturities-of-investments

9.79.740.539
61.9
103.4
101.4
59.6
26.9
13.4
6.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

8.220-0.6-0.6
-1.4
-0.3
-1
8.6
7.3
-1.1
-1.9
0
0
0
0
-0.1
0
-0.1
0.2
0.1
-0.1
0
-0.1
-0.5
-0.2
-0.9
-1.1
-0.6
-0.1

cash-flows.row.net-cash-used-for-investing-activites

8.668.712.48.3
13.6
52.8
-20.1
-25.7
-49.6
-2.7
-3.4
-13.2
-0.2
-0.2
-0.1
-0.1
-0.1
-0.1
0.1
-0.1
-0.3
-0.2
-0.2
-0.7
-0.3
-1
-1.4
-0.7
-0.1

cash-flows.row.debt-repayment

-1.46-10-1.3-0.4
-0.4
0
0
0
0
-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

32.85433.143.2
0.4
1.5
0.6
83.8
0.2
104.2
44.9
19.9
14.4
0
0.3
0
0.9
0
0
0
0
0.1
0
0
0
0
0.3
6.2
0

cash-flows.row.common-stock-repurchased

000.20.3
0
0
-45.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.1
-0.1
-0.1
-0.2
0
0
0

cash-flows.row.dividends-paid

000-0.3
0
0
0
0
0
0
0
0
0
-6.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-23.96-1-0.40.4
11.6
5.4
170.3
6.6
1.5
0.8
0.9
21
0.1
6.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

9.02931.643.2
11.6
6.8
125.8
90.4
1.8
104.8
45.7
40.9
14.5
0.2
0.3
0
0.9
0
0
0
0
0.1
-0.1
-0.1
-0.1
-0.2
0.3
6.2
0

cash-flows.row.effect-of-forex-changes-on-cash

-0.25-0.3-0.3-0.1
-0.1
-0.1
-0.1
0.3
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-7.8
0

cash-flows.row.net-change-in-cash

-22.77-22.8-54.1
-25.2
-5.2
37.7
9.3
-101.3
67
23.5
18
13.5
0.5
-0.6
-0.4
-0.2
-1.6
-2.6
-1.7
-1.5
0.1
-0.9
-0.8
0.1
-0.2
2.6
-1.4
1

cash-flows.row.cash-at-end-of-period

90.9912.134.939.9
35.8
61
66.3
28.5
19.2
120.6
53.6
30
14.3
0.8
0.3
0.9
1.2
1.4
3
5.6
7.2
8.7
8.6
9.5
10.4
10.3
10.4
0
1.4

cash-flows.row.cash-at-beginning-of-period

113.7634.939.935.8
61
66.3
28.5
19.2
120.6
53.6
30
12.1
0.8
0.3
0.9
1.2
1.4
3
5.6
7.2
8.7
8.6
9.5
10.4
10.3
10.4
7.9
1.4
0.4

cash-flows.row.operating-cash-flow

-40.2-40.2-48.7-47.3
-50.4
-64.8
-67.8
-55.7
-53.4
-35.1
-18.8
-9.7
-0.8
0.4
-0.8
-0.2
-1
-1.5
-2.6
-1.6
-1.2
0.2
-0.7
-0.1
0.4
1
3.7
0.9
1.1

cash-flows.row.capital-expenditure

-1.03-1-0.6-0.6
-1.4
-0.3
-1
-3
-2.4
-3.7
-1.9
-1.2
-0.1
-0.1
0
-0.1
-0.1
0
-0.1
-0.1
-0.1
-0.1
0
-0.1
0
0
-0.2
-0.1
0

cash-flows.row.free-cash-flow

-41.23-41.2-49.3-47.9
-51.8
-65.1
-68.8
-58.7
-55.8
-38.8
-20.7
-10.9
-0.9
0.4
-0.8
-0.3
-1.1
-1.5
-2.7
-1.7
-1.3
0
-0.7
-0.1
0.4
1
3.5
0.8
1.1

Kasumiaruande rida

Accelerate Diagnostics, Inc. tulud muutusid võrreldes eelmise perioodiga -0.054%. AXDX brutokasum on teatatud 2.55. Ettevõtte tegevuskulud on 56.58, mille muutus võrreldes eelmise aastaga on -14.416%. Kulud amortisatsioonikulud on 3.25, mis on -0.021% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 56.58, mis näitab -14.416% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 0.140% kasvu võrreldes eelmise aastaga. Tegevustulu on -54.03, mis näitab -0.140% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.014%. Eelmise aasta puhaskasum oli -61.62.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996

income-statement-row.row.total-revenue

12.0312.112.811.8
11.2
9.3
5.7
4.2
0.2
0.1
0.1
0
0.2
1.1
2.2
1.3
0.5
0.2
0.2
0.5
0.1
0.9
0.7
0.9
1.6
2.9
7.4
2.5
2.1

income-statement-row.row.cost-of-revenue

9.519.59.412.2
6.7
4.9
3.2
1
0
0
0
0
0
0
0
0
0
0.1
0
0.2
0.1
0.1
0.2
0.5
0.6
1.2
1.2
0.3
0.3

income-statement-row.row.gross-profit

2.522.53.3-0.4
4.5
4.4
2.5
3.2
0.2
0.1
0.1
0
0.2
1.1
2.2
1.3
0.5
0.1
0.2
0.3
0.1
0.7
0.5
0.3
0.9
1.7
6.2
2.2
1.8

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

25.38---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0.0413.1-0.20
-0.1
0
0
-0.2
2.4
1.8
0.9
0
0.2
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.5
0.2
0.6
0.9
0
0
0.2
0.1

income-statement-row.row.operating-expenses

56.6156.666.171.2
68.2
77.2
82.9
67.4
66.7
45.7
31.6
15.3
3.6
1.5
1.6
1.9
2.2
2.2
3.4
2.6
1.8
2.2
1.2
1.8
3.2
2.2
2.3
1.4
0.6

income-statement-row.row.cost-and-expenses

63.7366.175.683.3
74.9
82.1
86
68.4
66.7
45.7
31.6
15.3
3.6
1.5
1.6
1.9
2.2
2.3
3.4
2.8
1.9
2.4
1.4
2.3
3.9
3.4
3.5
1.7
0.9

income-statement-row.row.interest-income

1.121.10.60.1
0.9
2.8
2.8
0.9
0.5
0.1
0.1
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

7.747.73.815.5
15.6
14.3
10.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

13.8-6.70.2-6.1
-14.5
-11.6
-0.5
-0.3
-0.1
0.1
0
0
-2
0
0
-0.1
0
0.1
0
0
0
-0.1
-0.1
-1
0.3
0.6
0.5
0.3
-1.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0.0413.1-0.20
-0.1
0
0
-0.2
2.4
1.8
0.9
0
0.2
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.5
0.2
0.6
0.9
0
0
0.2
0.1

income-statement-row.row.total-operating-expenses

13.8-6.70.2-6.1
-14.5
-11.6
-0.5
-0.3
-0.1
0.1
0
0
-2
0
0
-0.1
0
0.1
0
0
0
-0.1
-0.1
-1
0.3
0.6
0.5
0.3
-1.2

income-statement-row.row.interest-expense

7.747.73.815.5
15.6
14.3
10.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

3.723.33.32.6
3.8
5.4
2.6
2.2
2.4
1.8
0.9
0.4
0.2
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.6
0.9
0.7
0.3
0.2
0.1

income-statement-row.row.ebitda-caps

-47.47---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-51.7-54-62.8-71.6
-63.7
-72.8
-80.4
-64.2
-66.5
-45.5
-31.5
-15.3
-5.4
-0.4
0.6
-0.7
-1.7
-2.1
-3.2
-2.3
-1.8
-1.5
-0.8
-1.4
-2.3
-0.5
3.9
0.8
1.2

income-statement-row.row.income-before-tax

-54.01-60.8-62.6-77.7
-78.2
-84.4
-88.1
-63.5
-66.1
-45.5
-31.5
-15.3
-5.3
-0.4
0.6
-0.7
-1.7
-1.9
-3
-2.1
-1.7
-1.4
-0.7
-1.9
-1.5
0
4.4
1.2
1.1

income-statement-row.row.income-tax-expense

20.8-0.10
0
-0.1
0.2
-0.7
0.3
0.1
-0.5
0
2
0.4
-0.6
0.7
0
-0.2
-0.2
-0.2
-0.8
0
-0.3
-0.3
-0.5
0
1.6
0.2
-1.1

income-statement-row.row.net-income

-56.02-61.6-62.5-77.7
-78.2
-84.3
-88.3
-62.9
-66.4
-45.5
-30.9
-15.3
-5.3
-0.4
0.6
-0.7
-1.7
-1.9
-3
-2.1
-0.9
-1.4
-0.4
-1.5
-0.9
0.1
2.9
1
1.1
Sarnased aktsiad
Sind võib huvitada ka:
EW
Edwards Lifesciences Corporation.
85.25 USD
NYSE
SOFW.TA
SofWave Medical Ltd..
1748 ILA
TLV
4549.T
Eiken Chemical Co., Ltd..
2002 JPY
JPX
688580.SS
Nanjing Vishee Medical Technology Co., Ltd.
45.89 CNY
SHH
USAQ
QHSLab, Inc..
0.08685 USD
PNK
QLIFE.ST
Qlife Holding AB (publ).
0.003 SEK
STO
VITR.ST
Vitrolife AB (publ).
175.2 SEK
STO
LFWD
ReWalk Robotics Ltd..
4.87 USD
NASDAQ
BBLG
Bone Biologics Corporation.
1.85 USD
NASDAQ
300298.SZ
Sinocare Inc..
23.89 CNY
SHZ
HYPR
Hyperfine, Inc..
0.8 USD
NASDAQ

Korduma kippuv küsimus

Mis on Accelerate Diagnostics, Inc. (AXDX) koguvara?

Accelerate Diagnostics, Inc. (AXDX) koguvara on 31366000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on 6299000.000.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.210.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -2.830.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -4.656.

Mis on ettevõtte kogutulu?

Kogutulu on -4.297.

Mis on Accelerate Diagnostics, Inc. (AXDX) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -61618000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 39220000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 56578000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 12138000.000.